Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call

Core Viewpoint - Charles River Laboratories International, Inc. is set to release its fourth-quarter and full-year 2025 financial results along with guidance for 2026 on February 18, before the market opens [1] Group 1 - A conference call to discuss the financial results and guidance will take place on February 18 at 8:30 a.m. ET [1] - Investors can access a live webcast of the conference call through the Investor Relations section of the company's website [2] - A replay of the conference call will also be available on the same website [2] Group 2 - Charles River Laboratories provides essential products and services to pharmaceutical and biotechnology companies, government agencies, and academic institutions globally [3] - The company focuses on accelerating research and drug development efforts for its clients [3] - Charles River's dedicated employees aim to improve and expedite the discovery, early-stage development, and safe manufacture of new therapies [3]